BRIEF-Health canada says four Canadian clinical trials, involving cancer medicine zydelig (idelalisib) in combination with other cancer medicines, being stopped

Thu Mar 17, 2016 6:01pm EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

March 17 (Reuters) - Gilead Sciences Inc

* International clinical trials, including trials in Canada, are being stopped due to serious adverse events with the drug zydelig, in combination with other cancer drugs

* Is also conducting a review of drug zydelig and will take appropriate next steps as needed

* Says three additional trials will be amended by implementing added measures to protect participants

* Four Canadian clinical trials, involving cancer medicine zydelig (idelalisib) in combination with other cancer medicines, being stopped Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)